Sort
51,593 grants matching “hepatitis”
Childhood infection and prevention of obesity
$705,560Julie Parsonnet · Stanford University · R01 · FY2013 · HD
Vascular delivery of nanocarriers by erythrocyres
$705,544Vladimir R Muzykantov · University Of Pennsylvania · R01 · FY2020 · HL
Decoding the grammar of transcriptional enhancers regulating different stages of opioid use disorder
$705,490Francesca Telese · University Of California, San Diego · U01 · FY2022 · DA
Baltimore Acute Hepatitis C Cooperative Center
$705,407Andrea L Cox · Johns Hopkins University · U19 · FY2013 · AI
Colorado Center for Childhood Liver Disease Research and Education
$705,265Ronald J Sokol · University Of Colorado Denver · U01 · FY2011 · DK
The NRF2-FBP1 crossregulatory loop and the control of healthy and diseased liver metabolism
$705,251Michael Karin · University Of California, San Diego · R01 · FY2022 · DK
Multifidelity and multiscale modeling of the spleen function in sickle cell disease with in vitro, ex vivo and in vivo validations
$705,243George Karniadakis · Brown University · R01 · FY2020 · HL
Mechanisms of viral proteases in coronavirus replication and pathogenesis
$705,182Susan C. Baker · Loyola University Chicago · R01 · FY2019 · AI
Chlamydial Vaccine Testing in Mice and Guinea Pigs
$705,162Nilu Goonetilleke · Univ Of North Carolina Chapel Hill · U19 · FY2022 · AI
Integrated software application for management of Hepatitis C Virus data
$705,108Johanna C Craig · Gataca, Llc · R44 · FY2013 · AI
Decoding the grammar of transcriptional enhancers regulating different stages of opioid use disorder
$705,105Francesca Telese · University Of California, San Diego · U01 · FY2021 · DA
Coagulation Control To Protect Gaitko Lung and Liver Xenografts
$705,015Richard N Pierson · University Of Pittsburgh At Pittsburgh · U19 · FY2014 · AI
Long-term Effects of IDU, HIV, HCV and the Impact of HCV Cure on Immune Activation and Liver Fibrosis in Aging Women
$705,013Andrea A. Kovacs · University Of Southern California · R01 · FY2018 · DA
Multi-Omics Characterization of Plasmodium Vivax Hypnozoites
$705,012David Serre · University Of Maryland Baltimore · R01 · FY2024 · AI
Nuclear receptors: action, functions, and roles in disease
$704,937Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES
Adiponectin and CTRP9 signaling in muscle and liver
$704,872Harvey F Lodish · Whitehead Institute For Biomedical Res · R01 · FY2008 · DK
Pathogenesis of Dyslipidemia and Atherosclerosis in the Diabetic State
$704,867Sudha B Biddinger · Boston Children'S Hospital · R01 · FY2023 · HL
ECONOMIC COST OF DRUG USE AND ABUSE
$704,854Rosalie Pacula · Rand Corporation · R01 · FY2006 · DA
Oral Vaccination for AIDS Prevention in Rhesus Macaques
$704,829Anna Aldovini · Boston Children'S Hospital · R01 · FY2009 · DE
Human population based genetic studies to elucidate the biology of NAFLD
$704,811Elizabeth K Speliotes · University Of Michigan At Ann Arbor · R01 · FY2017 · DK
Effects of aging on primary and secondary vaccine responses in a 15-year longitudinal cohort
$704,782Scott Dexter Boyd · Stanford University · R01 · FY2021 · AI
Dysregulated neutrophil subpopulations as a driving mechanism of liver and gastrointestinal disease in HIV-1-infected individuals
$704,750Zdenek Hel · University Of Alabama At Birmingham · R01 · FY2024 · DK
TIM recognition of phosphatidylserine regulates innate and adaptive immunity
$704,658Dale T Umetsu · Boston Children'S Hospital · P01 · FY2013 · AI
Increasing Involvement of MSM in the Continuum of Care in Kazakhstan
$704,557Elwin Wu · Columbia Univ New York Morningside · R01 · FY2016 · DA
Immune correlates of acute HBV recovery with and without HIV
$704,503Chloe L Thio · Johns Hopkins University · R01 · FY2015 · AI